March 9th

Pre-congress Courses/ Workshops


16h00 – 19h00 Neuropsychologic evaluation of MS patients with BRBN-T battery
Chairpersons: Cláudia Sousa (Portugal); Ana Passos (Portugal)

Introduction to Multiple Sclerosis
Speaker: Andreia Costa (Portugal)

Cognitive aspects of Multiple Sclerosis
Speaker: Cláudia Sousa (Portugal)

Introduction to the Rao’s Brief Repeatable Battery of Neuropsychological Tests (BRBN-T)
Speaker: Cláudia Sousa (Portugal)

Performance of individual tests with video guidance
Speaker: Mariana Neves (Portugal); Cláudia Sousa (Portugal)

Demonstration of tests quotation/interpretation
Speaker: Mariana Neves (Portugal); Cláudia Sousa (Portugal)


16h00 – 17h30 Clinical investigation and role of pharmaceuticals in MS teams
Chairperson: Paulo Carinha (Portugal)

Pharmacist activities in clinical trials; legistation, patient monitoring, audits and inspetions

Pharmacist contribution in clinical trial protocols evaluation

Role of pharmacist in Managed Acess Programs and compassionate use
Speaker: Paulo Carinha (Portugal); Patrocínia Rocha (Portugal); Elsa Branco (Portugal)

17h30 – 19h30 MS nurse: from theory to practice
Chairpersons: Fátima Lopes (Portugal), Liliana Mendonça (Portugal)

Key points: MS nurse consultation
Speaker: Macarena Rus (Spain)

Learning guides: innovation in MS therapeutic education
Speaker: Matilde Cabral ( Representing a multidisciplinary team / Portugal)


March 10th


09h00 – 09h15 Opening ceremony
Maria José Sá (CHSJ, Portugal); Carolina Garrett (CHSJ, Portugal); António Oliveira e Silva (CHSJ, Portugal)

09h15 – 11h15 Roundtable “The world of MS, MS in the world”
Chairpersons: Pedro Abreu (Portugal); Vasco Salgado (Portugal)

MS in the Western World
Peter Rieckmann (Germany)

The changing epidemiology of MS in the Middle East
Bassem Yamout (Lebanon)

MS in Australia
Allan Kermode (Australia)

MS in Asia
Kazuo Fujihara (Japan)

MS in Latin America
Edgardo Cristiano (Argentina)

11h15 – 11h30 Coffee break

11h30 – 12h00 MS – the future is now
Chairperson: José Vale (Portugal); Armando Sena (Portugal)
Speaker: Jorge Santos Silva (Switzerland)

12h00 – 12h30 Genes and environment in MS
Chairpersons: João de Sá (Portugal)
Speaker: Ana Martins da Silva (Portugal)

12h30 – 13h00 Oral presentations session 1
Chairpersons: João Vasconcelos (Portugal); Maria do Carmo Macário (Portugal)

13h00 – 14h15 Lunch


14h15 – 14h45 Opening conference
Chairperson: Maria José Sá (Portugal)

Portuguese pioneers in Medical Sciences
Joaquim Fernandes (UFP, Portugal)

14h45 – 17h00 “Hot topics in MS” roundabouts
Chairpersons: Rui Pedrosa (Portugal); Lívia Sousa (Portugal)

Redefining the diagnosis
Wallace Brownlee (UK)

Management of Pediatric MS
Angelo Ghezzi (Italy)

Rehabilitation in MS: timing and patient-centric outcomes
Jurg Kesselring (Switzerland)

Progressive solitary sclerosis
Mark Keegan (Mayo Clinic Rochester, USA)

17h00 – 18h00 E-poster session 1*
Chairpersons: Teresa Mendonça (Portugal), Sónia Batista (Portugal),
Armando Morganho (Portugal); Cláudia Sousa (Portugal); Pedro Barros (Portugal)
* Complimentary coffee will be served


March 11th


08h30 – 09h00 E-poster session 2
Chairpersons: Jorge Reis (Portugal); Irene Mendes (Portugal); David Costa (Portugal); Joana Guimarães (Portugal)

09h00 – 10h30 “Look at the present to set the future”
Chairpersons: João Cerqueira (Portugal); Maria José Sá (CHSJ, Portugal)

         The burden of MS in Portugal
       Maria José Sá (CHSJ, Portugal)

New medicine landscape
Patrick Vermersch (France)

Therapy of the Future
Irati Zubizarreta (Spain)

Digital patient engagement
Jennifer Kilian (USA)

10h30 – 11h00 Oral presentations session 2
Chairpersons: Edite Rio (Portugal); Filipe Palavra (Portugal)

11h00 – 11h30 Coffee break

11h30 – 12h45 “Ten-minute vignettes with 10 take-home messages for clinical practice”
Chairpersons: Joaquim Pinheiro (Portugal); José Pinto-Marques (Portugal)

Bayer: Betaferon®: Long Lasting Benefits in MS
Eva-Maria Wicklein, Bayer HealthCare, Germany

Biogen: The Brain Company
Anabela Fernandes & Rita Lau, Biogen, Portugal

Sanofi Genzyme: Sanofi Genzyme commitment to MS
Marianne Berrens, Sanofi Genzyme, Netherlands

Merck: Paradigm shifts in the Treatment of MS
Ali-Frederic Ben-Amor, Merck s.a., Switzerland

Novartis: MS: are we spending or investing?
Ricardo Viana, Novartis Pharma AG, Switzerland

Roche: “Why Times Matters in MS”
Licínio Craveiro, Roche, Portugal

          Teva: The heritage of Copaxone in Portugal
        Inês Iglésias, Teva, Portugal

12h45 – 13h00 Prizes “MS Porto”

13h00 Farewell lunch